← Back to front page
United States · Platforms & data · Barchart

Actinium Pharmaceuticals Announces ASH 2026 Abstract Highlighting Long-Term Results of Actimab-A in Combination with CLAG-M in Relapsed or Refractory AML

Published by Barchart · United States 2 h ago
Read the full article on Barchart Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (news.google.com)

Also worth reading

The Motley Fool

AI Regulation Was on the Ballot In These States. Here Are The Elon Musk Stocks That Could Be Impacted.

 MarketBeat

Wells Fargo & Company Forecasts Strong Price Appreciation for American Well (NYSE:AMWL) Stock

 Seeking Alpha

IREN Q1 earnings on deck: what to expect

 CNBC

10-year Treasury yield is little changed as traders mull over Democrats' midterm victories

 Benzinga

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

 Investing.com

Gulfport Energy earnings up next: Data centers vs. weak gas prices